HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Chanson Selected Research

Sodium

1/2020Cortisol and Aldosterone Responses to Hypoglycemia and Na Depletion in Women With Non-Classic 21-Hydroxylase Deficiency.
4/2014Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.
6/2012Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?
7/2011Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity.
7/2008Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Chanson Research Topics

Disease

71Acromegaly
02/2024 - 01/2005
43Neoplasms (Cancer)
05/2024 - 07/2004
30Pituitary Neoplasms (Pituitary Adenoma)
05/2024 - 11/2003
20Cushing Syndrome
04/2024 - 07/2004
15Adenoma (Adenomas)
02/2024 - 11/2003
13Hypogonadism (Hypergonadotropic Hypogonadism)
12/2023 - 12/2003
13Prolactinoma (Prolactinomas)
12/2023 - 09/2009
12Pituitary ACTH Hypersecretion
04/2024 - 04/2012
11Hyperprolactinemia
12/2023 - 01/2008
8Hypertension (High Blood Pressure)
11/2023 - 07/2004
8Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 05/2014
6Hyperplasia
02/2024 - 06/2008
6Insulin Resistance
12/2022 - 05/2004
5Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2023 - 09/2011
5Carcinogenesis
01/2019 - 10/2006
4Headache (Headaches)
12/2023 - 06/2020
4Growth Hormone-Secreting Pituitary Adenoma
11/2021 - 01/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 01/2010
4Kallmann Syndrome (Kallmann's Syndrome)
02/2020 - 05/2010
4Type 2 Diabetes Mellitus (MODY)
01/2020 - 02/2014
3Obesity
03/2024 - 02/2010
3Chronic Disease (Chronic Diseases)
11/2023 - 02/2005
3Adrenocortical Adenoma (Disease, Conn's)
12/2021 - 06/2007
3Infertility (Sterility)
05/2021 - 01/2008
3Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 12/2018
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 02/2002
3Primary Hyperparathyroidism
01/2019 - 08/2009
3Diabetes Mellitus
01/2018 - 07/2011
3Amenorrhea
11/2017 - 10/2008
3Adrenocortical Carcinoma
02/2015 - 09/2010
2Craniopharyngioma (Craniopharyngiomas)
03/2024 - 01/2024
2Diabetes Insipidus
02/2024 - 01/2019
2Thyroid Nodule (Nodule, Thyroid)
12/2023 - 12/2023
2Mitochondrial Diseases (Mitochondrial Disease)
05/2023 - 01/2023
2Hypokalemia
01/2023 - 05/2014
2Hyperglycemia
01/2023 - 12/2022
2Carcinoma (Carcinomatosis)
11/2022 - 10/2010
2Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
03/2022 - 01/2020
2Hyperparathyroidism
03/2022 - 01/2020
2Combined Pituitary Hormone Deficiency
06/2021 - 05/2010
2Endocrine System Diseases (Endocrine Diseases)
05/2021 - 06/2015
2Hyperthyroidism
01/2021 - 05/2017

Drug/Important Bio-Agent (IBA)

35Insulin-Like Growth Factor I (IGF-1)IBA
11/2023 - 12/2006
29Growth Hormone (Somatotropin)IBA
02/2024 - 01/2007
18ProlactinIBA
12/2023 - 11/2003
17Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2022 - 02/2002
15Hydrocortisone (Cortisol)FDA LinkGeneric
04/2024 - 07/2004
13Hormones (Hormone)IBA
12/2023 - 12/2003
12Adrenocorticotropic Hormone (ACTH)FDA Link
04/2024 - 07/2004
12Glucose (Dextrose)FDA LinkGeneric
02/2024 - 05/2009
12Dopamine Agonists (Dopamine Agonist)IBA
12/2023 - 01/2008
12Insulin (Novolin)FDA Link
05/2021 - 06/2005
10pegvisomantFDA LinkGeneric
12/2021 - 12/2006
8Somatostatin Receptors (Somatostatin Receptor)IBA
12/2022 - 07/2005
8GonadotropinsIBA
01/2022 - 12/2003
8CabergolineFDA LinkGeneric
11/2017 - 01/2008
7CalciumIBA
12/2023 - 08/2009
7LigandsIBA
12/2022 - 07/2005
6Antidepressive Agents (Antidepressants)IBA
01/2023 - 10/2015
5gastric inhibitory polypeptide receptorIBA
02/2024 - 01/2017
5GlucocorticoidsIBA
01/2022 - 01/2010
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2020 - 06/2009
5SodiumIBA
01/2020 - 07/2008
5Biomarkers (Surrogate Marker)IBA
09/2019 - 11/2003
5aryl hydrocarbon receptor-interacting proteinIBA
09/2017 - 07/2007
5Proteins (Proteins, Gene)FDA Link
09/2017 - 10/2006
5Vitamin DFDA LinkGeneric
12/2016 - 09/2011
4DNA (Deoxyribonucleic Acid)IBA
02/2024 - 09/2011
4Peptides (Polypeptides)IBA
02/2024 - 02/2014
4Temozolomide (Temodar)FDA LinkGeneric
11/2022 - 10/2010
4Phosphates (Orthophosphate)IBA
01/2020 - 06/2012
4Mitotane (Lysodren)FDA Link
02/2015 - 09/2010
3Vasopressins (Vasopressin)IBA
02/2024 - 12/2011
3HDL CholesterolIBA
08/2023 - 01/2010
3Insulin-Like PeptidesIBA
12/2022 - 06/2021
3Dexamethasone (Maxidex)FDA LinkGeneric
03/2022 - 09/2009
3SteroidsIBA
02/2021 - 07/2015
3Furosemide (Lasix)FDA LinkGeneric
01/2020 - 07/2011
3AndrogensIBA
01/2020 - 06/2007
32- (4- methyl- 2- thiazolylazo)- 5- diethylaminophenolIBA
12/2018 - 10/2015
3MetyraponeFDA Link
12/2017 - 09/2011
3Ketoconazole (Nizoral)FDA LinkGeneric
04/2015 - 09/2011
2pasireotideIBA
12/2022 - 11/2022
2Antipsychotic Agents (Antipsychotics)IBA
12/2022 - 08/2020
2Octreotide (Sandostatin)FDA LinkGeneric
11/2022 - 07/2005
2Ga(III)-DOTATOCIBA
05/2022 - 01/2020
2Parathyroid Hormone (Parathormone)IBA
03/2022 - 01/2020
2LipidsIBA
11/2021 - 06/2021
2amsonic acid (DAS)IBA
08/2020 - 01/2019
2methylamphotericin B (AME)IBA
01/2020 - 01/2020
2ReninIBA
01/2020 - 07/2011
2AldosteroneIBA
01/2020 - 07/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 02/2018
2RNA (Ribonucleic Acid)IBA
01/2019 - 01/2018

Therapy/Procedure

38Therapeutics
05/2024 - 01/2005
14Radiotherapy
05/2024 - 07/2005
9Aftercare (After-Treatment)
08/2023 - 06/2008
4Adrenalectomy
12/2022 - 06/2007
2Operative Surgical Procedures
05/2024 - 01/2019
2Immunotherapy
11/2022 - 10/2018